Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Heated eye mask does not enhance IPL therapy outcomes in dry eye patients
  • Ocular Surface Disease

Heated eye mask does not enhance IPL therapy outcomes in dry eye patients

Kelsey Moroz

The additional use of a heated eye mask in combination with intense pulsed light (IPL) therapy in patients with evaporative dry eye disease does not appear to provide a substantial advantage over IPL therapy alone, according to a study.

The study included 110 patients with evaporative dry eye disease, divided into 2 groups: IPL therapy only (n = 73) and IPL therapy in conjunction with the Posiforlid heated eye mask (n = 37). Assessments were carried out at baseline; during IPL sessions; at the end of treatment; and at 3, 6, and 12 months post-treatment.

Both groups showed increased tear film stability and improved symptoms. Key points from the evaluations included:

  • Tear Film Stability Evaluation (TFSE):
    • Control group: Improved from 310.56 ± 389.54 at baseline to 114.40 ± 122.90 after 12 months.
    • Heated mask group: Improved from 391.11 ± 456.45 to 97.38 ± 105.98 after 12 months.
  • Non-Invasive Average Breakup Time (NIABUT):
    • Control group: Increased from 10.72 ± 4.90 seconds to 14.79 ± 3.72 seconds.
    • Heated mask group: Increased from 11.11 ± 5.08 seconds to 15.84 ± 2.26 seconds.
  • Ocular Surface Inflammatory Evaluation (OSIE):
    • Decreased significantly in both groups with no significant differences between them.
  • Symptomatology Scores (measured by EFT):
    • Control group: Improved from 29.99 ± 8.60 to 39.10 ± 5.08.
    • Heated mask group: Improved from 27.35 ± 9.24 to 38.35 ± 4.62.

The study concluded that while both treatment strategies improved tear film stability, ocular surface inflammation, and patient symptoms, the additional use of a Posiforlid heated eye mask did not significantly enhance these outcomes compared to IPL therapy alone.

Reference
Pac CP, Ferrari F, Mercea N, et al. Efficiency of Combining Heated Eye Mask with Intense Pulsed Light Therapy as a Treatment Option for Evaporative Dry Eye Disease. Rom J Ophthalmol. 2024;68(2):158-165. doi: 10.22336/rjo.2024.29. PMID: 39006323; PMCID: PMC11238869.

 

Share

Related Content

  • Ocular Surface Disease

Childhood-onset allergic eye disease linked to greater ocular morbidity

  • Ocular Surface Disease

Perceived stress may precede worsening dry eye symptoms in young adults

  • Ocular Surface Disease

Post-menopausal women show more severe evaporative dry eye disease

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Ocular Surface Disease

Spotlight on VEVYE®

  • Ocular Surface Disease

Intervening early in dry eye disease: reducing patient cost and disease burden

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon